Beverly A. Heinz

3.2k citations

43 papers · 1.2k indexed · h-index 19

Molecular Biology
Organic Chemistry top 5%
Cellular and Molecular Neuroscience top 10%
Hepatology top 5%
Epidemiology

Co-authors: Chafiq Hamdouchi Joseph M. Gruber Lori Vance Jesús de Blas Q. May Wang Allen D. Kline C. Cheng Kao Daryl F. Venable
Topics: Neuroscience and Neuropharmacology Research (11 papers)Receptor Mechanisms and Signaling (11 papers)Viral Infections and Immunology Research (8 papers)
Cited by: Hepatology Organic Chemistry Cellular and Molecular Neuroscience
Journals: Journal of Molecular Biology Journal of Virology The FASEB Journal
Partner nations: United States Spain United Kingdom

In The Last Decade

Beverly A. Heinz

41 papers receiving 1.2k citations

Peers

Countries citing papers authored by Beverly A. Heinz

Since Specialization

Citations

This map shows the geographic impact of Beverly A. Heinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Heinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Heinz more than expected).

Fields of papers citing papers by Beverly A. Heinz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Heinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Heinz. The network helps show where Beverly A. Heinz may publish in the future.

Co-authorship network of co-authors of Beverly A. Heinz

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Heinz. A scholar is included among the top collaborators of Beverly A. Heinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Heinz. Beverly A. Heinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of high-throughput analytical methods for characterization and quantitation of rAAV genome integrity 2025 ·Molecular Therapy — Methods & Clinical Development ·Xushan Wang,Zhaohui Yang,(unknown),Mah Lee Ng,(unknown),(unknown),(unknown),(unknown),Sabine Wenzel,(unknown),(unknown),Brandon L. Doyle,Meng Zhao,(unknown),Jorge F. Haller,Garrett Daniels,Stuart Nelson,Beverly A. Heinz,(unknown)	0
2	The atypical ‘hippocampal’ glutamate receptor coupled to phospholipase D that controls stretch‐sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2 2023 ·Experimental Physiology ·Karen Thompson,(unknown),Chiara Zanato,Sergio Dall’Angelo,(unknown),(unknown),Fiona C. Shenton,Helen Sanger,Beverly A. Heinz,Lisa M. Broad,Noëlle Grosjean,(unknown),(unknown),Susan Pyner,Iain R. Greig,Matteo Zanda,David Bleakman,Robert W. Banks,Guy S. Bewick	12
3	Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor 2018 ·Molecular Pharmacology ·Xushan Wang,Beverly A. Heinz,Yuewei Qian,(unknown),Robert A. Gadski,Lisa S. Beavers,Sheila P. Little,Charles R. Yang,James P. Beck,Junliang Hao,John M. Schaus,Kjell Svensson,Robert F. Bruns	26
4	Translational Pharmacology of the Metabotropic Glutamate 2 Receptor–Preferring Agonist LY2812223 in the Animal and Human Brain 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Christian C. Felder,Douglas A. Schober,Yuan Tu,(unknown),(unknown),Marla L. Watt,(unknown),Eric S. Nisenbaum,Chuanxi Xiang,Beverly A. Heinz,Lourdes Prieto,David L. McKinzie,James A. Monn	5
5	In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist 2015 ·Neuropharmacology ·Jeffrey M. Witkin,Paul L. Ornstein,Charles H. Mitch,Renhua Li,(unknown),Beverly A. Heinz,(unknown),Chuanxi Xiang,(unknown),Wesley H. Anderson,Xia Li,Lisa M. Broad,Francesca Pasqui,Stephen M. Fitzjohn,Helen Sanger,Jodi L. Smith,John T. Catlow,Steven Swanson,James A. Monn	18
6	Further Evaluation of the Neuropharmacological Determinants of the Antidepressant-Like Effects of Curcumin 2013 ·CNS & Neurological Disorders - Drug Targets ·Jeffrey M. Witkin,(unknown),Linda Thompson,(unknown),Chunjin Ding,Beverly A. Heinz,John T. Catlow,Scott D. Gleason,Xia Li	14
7	In vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat 2012 ·Neuropharmacology ·Gary Gilmour,Lisa M. Broad,Keith A. Wafford,Thomas C. Britton,(unknown),Adam M. Fivush,François Gastambide,(unknown),Beverly A. Heinz,(unknown),Lourdes Prieto,(unknown),Janice W. Smith,(unknown),Dale M. Edgar,Mark D. Tricklebank	42
8	3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity 2012 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Fisher,(unknown),Vanessa Barth,(unknown),Joseph M. Gruber,Beverly A. Heinz,Smriti Iyengar,Sean P. Hollinshead,Anne Kingston,(unknown),Lin Li,Eric S. Nisenbaum,Steven Peters,Lee A. Phebus,Rosa Maria A. Simmons,Ellen van der Aar	21
9	Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain 2012 ·European Journal of Nuclear Medicine and Molecular Imaging ·Paolo Zanotti‐Fregonara,Vanessa Barth,Jeih-San Liow,Sami S. Zoghbi,David Clark,(unknown),Edward R. Siuda,Beverly A. Heinz,Eric S. Nisenbaum,Bruce A. Dressman,Elizabeth Joshi,Debra Luffer‐Atlas,Matthew J. Fisher,John J. Masters,(unknown),(unknown),Cheryl L. Morse,J. Tauscher,Victor W. Pike,Robert B. Innis	16
10	Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer’s Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective 2010 ·Molecular Pharmacology ·Filippo Caraci,Gemma Molinaro,Giuseppe Battaglia,Maria Laura Giuffrida,Barbara Riozzi,Anna Traficante,Valeria Bruno,Milena Cannella,Sara Merlo,Xushan Wang,Beverly A. Heinz,Eric S. Nisenbaum,Thomas C. Britton,Filippo Drago,Maria Angela Sortino,Agata Copani,Ferdinando Nicoletti	100
11	Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors 2008 ·Molecular Pharmacology ·Ruud Zwart,Anna L. Carbone,Mirko Moroni,Isabel Bermúdez,Adrian J. Mogg,(unknown),Lisa M. Broad,(unknown),Deyi Zhang,Chunjin Ding,Beverly A. Heinz,Emanuele Sher	96
12	P4 cap modified tetrapeptidyl α-ketoamides as potent HCV NS3 protease inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Beverly A. Heinz,Alexander A. Kolykhalov,(unknown),Robert B. Johnson,(unknown),(unknown),Shu‐Hui Chen	13
13	Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Frantz Victor,(unknown),Robert B. Johnson,(unknown),(unknown),John I. Glass,Ling Jin,Lifei Liu,Daryl F. Venable,Mark Wakulchik,(unknown),Beverly A. Heinz,Elcira C. Villarreal,(unknown),Nathan Yumibe,Mark J. Tebbe,J. E. MUNROE,Shu‐Hui Chen	38
14	Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Hui Chen,(unknown),Frantz Victor,Nancy Snyder,Robert B. Johnson,Beverly A. Heinz,Mark Wakulchik,(unknown)	16
15	Demonstrating the intrinsic ion channel activity of virally encoded proteins 2003 ·FEBS Letters ·(unknown),James A. Cook,Patricia Brown‐Augsburger,Beverly A. Heinz,Michèle C. Smith,Lawrence H. Pinto	23
16	Recent advances in prevention and treatment of hepatitis C virus infections 2000 ·Birkhäuser Basel eBooks ·Q. May Wang,Beverly A. Heinz	11
17	Short synthesis and anti-rhinoviral activity of imidazo[1,2-a]pyridines: The effect of acyl groups at 3-position 1999 ·Bioorganic & Medicinal Chemistry Letters ·Chafiq Hamdouchi,Jesús Ezquerra,Juan A. Vega,Juan J. Vaquero,Julio Álvarez‐Buílla,Beverly A. Heinz	32
18	2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imidazo[1,2-a]pyridines as a Novel Class of Inhibitors of Human Rhinovirus: Stereospecific Synthesis and Antiviral Activity 1998 ·Journal of Medicinal Chemistry ·Chafiq Hamdouchi,Jesús de Blas,(unknown),Joseph M. Gruber,Beverly A. Heinz,Lori Vance	246
19	Structural Studies on Human Rhinovirus 14 Drug-resistant Compensation Mutants 1995 ·Journal of Molecular Biology ·Andrea T. Hadfield,(unknown),(unknown),Iwona Minor,Marcia J. Kremer,Beverly A. Heinz,D A Shepard,Daniel C. Pevear,Roland R. Rueckert,Michael G. Rossmann	36
20	Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 1989 ·Journal of Molecular Biology ·John Badger,Sriram Krishnaswamy,Marcia J. Kremer,Marcos Antônio de Oliveira,M.G. Rossmann,Beverly A. Heinz,Roland R. Rueckert,Frank J. Dutko,Mark A. McKinlay	26

About Beverly A. Heinz

Beverly A. Heinz is a scholar working on Hepatology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Viral Infections and Immunology Research (8 papers). The work is most often cited by research in Hepatology (203 citations), Organic Chemistry (395 citations) and Cellular and Molecular Neuroscience (244 citations). Beverly A. Heinz has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Chafiq Hamdouchi, Joseph M. Gruber, Lori Vance, Jesús de Blas, Q. May Wang, Allen D. Kline, C. Cheng Kao, Daryl F. Venable, Kevin L. McKnight and Lisa M. Broad. Their work appears in journals such as Journal of Molecular Biology, Journal of Virology and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact